drugset / Trial / NCT02272647

Progesterone Amplifies Estrogen-stimulated Growth Hormone Secretion in Older Women

NCT02272647

Phase 1 Completed 47 enrolled Mayo Clinic
RandomizedCrossoverSingle-blindBasic science

Summary

Progesterone amplifies estrogen-stimulated Growth Hormone (GH) secretion in postmenopausal women. Preliminary data are sought to estimate statistical power for more detailed studies of this hypothesis.

Timeline

Start
2014-12
Primary completion
2016-12
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified Oral
Subject estradiol valerate Unknown 5 mg Intramuscular
Subject medroxyprogesterone acetate Other / unclassified 5 mg
Background Ghrelin Peptide 0.3 ug/kg Intravenous

Indications

No indication recorded.